PL1699449T3 - Zastosowanie kompozycji kwasów tłuszczowych obejmującej co najmniej jeden z EPA i DHA lub jakąkolwiek ich kombinację - Google Patents
Zastosowanie kompozycji kwasów tłuszczowych obejmującej co najmniej jeden z EPA i DHA lub jakąkolwiek ich kombinacjęInfo
- Publication number
- PL1699449T3 PL1699449T3 PL04806374T PL04806374T PL1699449T3 PL 1699449 T3 PL1699449 T3 PL 1699449T3 PL 04806374 T PL04806374 T PL 04806374T PL 04806374 T PL04806374 T PL 04806374T PL 1699449 T3 PL1699449 T3 PL 1699449T3
- Authority
- PL
- Poland
- Prior art keywords
- dha
- epa
- combinations
- fatty acid
- acid composition
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Confectionery (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53064403P | 2003-12-19 | 2003-12-19 | |
| SE0303513A SE0303513D0 (sv) | 2003-12-19 | 2003-12-19 | Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| EP04806374.7A EP1699449B1 (en) | 2003-12-19 | 2004-12-17 | Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| PCT/IB2004/004178 WO2005060954A1 (en) | 2003-12-19 | 2004-12-17 | Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1699449T3 true PL1699449T3 (pl) | 2014-06-30 |
Family
ID=30768831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04806374T PL1699449T3 (pl) | 2003-12-19 | 2004-12-17 | Zastosowanie kompozycji kwasów tłuszczowych obejmującej co najmniej jeden z EPA i DHA lub jakąkolwiek ich kombinację |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9282760B2 (pl) |
| EP (2) | EP2301530A1 (pl) |
| JP (2) | JP2007514733A (pl) |
| CN (2) | CN1901897A (pl) |
| AU (1) | AU2004305325B2 (pl) |
| CA (1) | CA2549103C (pl) |
| ES (1) | ES2451030T3 (pl) |
| NO (1) | NO336507B1 (pl) |
| NZ (1) | NZ547831A (pl) |
| PL (1) | PL1699449T3 (pl) |
| SE (1) | SE0303513D0 (pl) |
| WO (1) | WO2005060954A1 (pl) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006017627A2 (en) * | 2004-08-06 | 2006-02-16 | Barry Sears | Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance |
| WO2006117664A1 (en) | 2005-05-04 | 2006-11-09 | Pronova Biopharma Norge As | New dha derivatives and their use as medicaments |
| ATE509624T1 (de) * | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
| CN101370490A (zh) * | 2005-12-29 | 2009-02-18 | 希尔氏宠物营养品公司 | 用于预防或治疗炎症性肠病的组合物及其制备方法 |
| WO2007100561A2 (en) * | 2006-02-28 | 2007-09-07 | Bristol-Myers Squibb Company | Use of dha and ara in the preparation of a composition for preventing or treating obesity |
| EP1886680A1 (en) * | 2006-05-23 | 2008-02-13 | Nestec S.A. | Maternal supplement |
| US20080076823A1 (en) * | 2006-08-09 | 2008-03-27 | Watkins Bruce A | Methods of improving bone health and muscle health |
| EP2102139A2 (en) | 2006-11-01 | 2009-09-23 | Pronova Biopharma Norge AS | Omega-3 lipid compounds |
| BRPI0717972A2 (pt) * | 2006-11-01 | 2013-11-12 | Pronova Biopharma Norge As | Lipídeos de ômega-3 alfa-substituídos que são ativadores ou moduladores do receptor ativado por proliferadores de peroxissoma (ppar) |
| CN101535238A (zh) * | 2006-11-01 | 2009-09-16 | 普罗诺瓦生物医药挪威公司 | 作为过氧化物酶体增生物激活受体(PPAR)的活化剂或调节剂的α-取代的ω-3脂质 |
| WO2008139261A2 (en) * | 2006-11-03 | 2008-11-20 | Pronova Biopharma Norge As | Omega-3 lipid compound |
| US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| US20090197955A1 (en) * | 2008-01-31 | 2009-08-06 | Monsanto Company | Methods of improving dha deposition and related function and/or development |
| WO2009134147A1 (en) * | 2008-05-02 | 2009-11-05 | Pronova Biopharma Norge As | Lipid compositions containing derivatives of epa and dha an their use thereof |
| PT2334295T (pt) | 2008-09-02 | 2017-09-15 | Amarin Pharmaceuticals Ie Ltd | Composição farmacêutica compreendendo ácido eicosapentanoico e ácido nicotínico e métodos de utilização dos mesmos |
| EP2405903B1 (en) * | 2009-03-09 | 2024-04-10 | Basf As | Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof |
| US8207363B2 (en) * | 2009-03-19 | 2012-06-26 | Martek Biosciences Corporation | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof |
| CN107233337A (zh) | 2009-04-29 | 2017-10-10 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
| SI2424356T1 (en) | 2009-04-29 | 2018-01-31 | Armarin Pharmaceuticals Ireland Limited | A stable pharmaceutical composition and procedures for its use |
| US20120136053A1 (en) | 2009-06-12 | 2012-05-31 | Calanus As | Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders |
| WO2010147994A1 (en) | 2009-06-15 | 2010-12-23 | Amarin Pharma, Inc. | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
| MX2012003555A (es) | 2009-09-23 | 2012-07-03 | Amarin Corp Plc | Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma. |
| US9370493B2 (en) * | 2009-10-23 | 2016-06-21 | Pronova Biopharma Norge As | Coated capsules and tablets of a fatty acid oil mixture |
| NZ601757A (en) | 2010-01-19 | 2015-01-30 | Dsm Ip Assets Bv | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof |
| JP5576699B2 (ja) * | 2010-04-15 | 2014-08-20 | 花王株式会社 | Ｇｉｐ上昇抑制剤 |
| US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| NZ727980A (en) | 2010-11-29 | 2018-08-31 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| WO2012087486A1 (en) * | 2010-12-20 | 2012-06-28 | Hill's Pet Nutrition, Inc. | Pet food compositions for inducing a satiety response |
| CA2840985A1 (en) | 2011-07-07 | 2013-01-10 | Mochida Phamaceutical Co., Ltd. | Anti-obesity agent comprising high-purity epa |
| BR122015020126B1 (pt) * | 2011-07-21 | 2022-03-03 | Dsm Ip Assets B.V | Composição contendo óleo microbiano diluído |
| JP2013063937A (ja) * | 2011-09-20 | 2013-04-11 | Kao Corp | Ｇｉｐ上昇抑制剤 |
| EP2775837A4 (en) | 2011-11-07 | 2015-10-28 | Amarin Pharmaceuticals Ie Ltd | METHODS OF TREATING HYPERTRIGLYCERIDEMIA |
| US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| CN104321055A (zh) | 2012-01-06 | 2015-01-28 | 翁特拉制药公司 | 游离酸形式的ω-3多不饱和脂肪酸的富含dpa组合物 |
| ES2891473T3 (es) | 2012-01-06 | 2022-01-28 | Amarin Pharmaceuticals Ie Ltd | Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto |
| US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
| US20160228397A1 (en) | 2012-03-30 | 2016-08-11 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
| IN2014DN08449A (pl) | 2012-03-30 | 2015-05-08 | Sancilio & Company Inc | |
| US10898458B2 (en) | 2012-03-30 | 2021-01-26 | Micelle Biopharma, Inc. | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states |
| US20130295173A1 (en) | 2012-05-07 | 2013-11-07 | Omthera Pharmaceuticals, Inc. | Compositions of statins and omega-3 fatty acids |
| EP3815684B1 (en) | 2012-06-29 | 2024-09-04 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy |
| WO2014074552A2 (en) | 2012-11-06 | 2014-05-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
| US9814733B2 (en) | 2012-12-31 | 2017-11-14 | A,arin Pharmaceuticals Ireland Limited | Compositions comprising EPA and obeticholic acid and methods of use thereof |
| US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
| US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
| US9662307B2 (en) | 2013-02-19 | 2017-05-30 | The Regents Of The University Of Colorado | Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof |
| US9283201B2 (en) | 2013-03-14 | 2016-03-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for treating or preventing obesity in a subject in need thereof |
| US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
| US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
| US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
| US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| ES2984970T3 (es) | 2013-12-20 | 2024-10-31 | Mara Renewables Corp | Métodos para recuperar aceite de microorganismos |
| BR112016028561A8 (pt) | 2014-06-06 | 2021-06-29 | Marine Ingredients Llc | composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas |
| US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
| WO2015195662A1 (en) | 2014-06-16 | 2015-12-23 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids |
| US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| US10851395B2 (en) | 2016-06-10 | 2020-12-01 | MARA Renewables Corporation | Method of making lipids with improved cold flow properties |
| CN107970232A (zh) * | 2016-10-21 | 2018-05-01 | 玛鲁哈日鲁株式会社 | 含n-3系不饱和脂肪酸的组合物、及n-3系不饱和脂肪酸在该组合物的制造中的应用 |
| AU2017380721B2 (en) | 2016-12-22 | 2021-04-01 | MARA Renewables Corporation | Methods for producing biomass rich in DHA, palmitic acid and protein using a eukaryotic microorganism |
| AU2018255269B2 (en) | 2017-04-17 | 2023-03-09 | The University Of Chicago | Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease |
| WO2018213663A1 (en) | 2017-05-19 | 2018-11-22 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
| AU2018354090B2 (en) | 2017-10-23 | 2024-10-24 | Epitracker, Inc. | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome |
| US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
| AU2019274431B2 (en) | 2018-05-23 | 2025-03-13 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
| CN108721269A (zh) * | 2018-07-10 | 2018-11-02 | 广东海洋大学 | 一种epa与dha混合剂在防治焦虑和快感缺乏方面的应用 |
| ES2983568T3 (es) | 2018-09-24 | 2024-10-23 | Amarin Pharmaceuticals Ie Ltd | Métodos para reducir el riesgo de eventos cardiovasculares en un sujeto |
| CN109463512A (zh) * | 2018-12-10 | 2019-03-15 | 瞿瀚鹏 | Dha油脂组合物在凝胶糖果中的应用以及凝胶糖果及其制备方法 |
| CN109646430A (zh) * | 2018-12-26 | 2019-04-19 | 江南大学 | n-3多不饱和脂肪酸在制备预防沙门氏菌感染药物中的应用 |
| WO2020146263A1 (en) | 2019-01-09 | 2020-07-16 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of neurodegenerative diseases |
| FR3092968B1 (fr) * | 2019-02-22 | 2021-05-21 | Microphyt | Complement alimentaire |
| JP7404382B2 (ja) | 2019-03-04 | 2023-12-25 | エピトラッカー インコーポレイテッド | 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用 |
| EP4058141A4 (en) | 2019-11-12 | 2023-11-22 | Amarin Pharmaceuticals Ireland Limited | METHOD FOR REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT WITH Atrial fibrillation and/or atrial flutter |
| CN115379763B (zh) * | 2020-02-06 | 2025-01-10 | 帝斯曼知识产权资产管理有限公司 | 用于增加动物血浆中二十碳五烯酸水平的方法 |
| MX2022012322A (es) | 2020-04-03 | 2022-11-10 | Mara Renewables Corp | Aceites microbianos con niveles altos de ácidos grasos omega-3. |
| WO2022040340A1 (en) * | 2020-08-20 | 2022-02-24 | Epitracker, Inc. | Compositions and methods for treatment of obesity |
| AU2022263358A1 (en) | 2021-04-21 | 2023-11-30 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of heart failure |
| US12370166B2 (en) | 2021-11-03 | 2025-07-29 | Epitracker, Inc. | Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US565667A (en) * | 1896-08-11 | Churn | ||
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| JPH0394655A (ja) | 1989-09-06 | 1991-04-19 | Otsuka Pharmaceut Co Ltd | 栄養補給用組成物 |
| JPH0398560A (ja) | 1989-09-09 | 1991-04-24 | Toa Kogyo Kk | 餃子と餃子製造機の成形用形枠 |
| US5013569A (en) * | 1990-05-21 | 1991-05-07 | Century Laboratories, Inc. | Infant formula |
| JP3092180B2 (ja) | 1991-02-27 | 2000-09-25 | 日本油脂株式会社 | 低密度リポ蛋白受容体活性化剤 |
| JP3098560B2 (ja) | 1991-03-28 | 2000-10-16 | 花王株式会社 | 体重増加抑制剤 |
| JPH06116585A (ja) | 1992-10-09 | 1994-04-26 | Kanegafuchi Chem Ind Co Ltd | 油脂の精製方法 |
| TW360501B (en) * | 1996-06-27 | 1999-06-11 | Nestle Sa | Dietetically balanced milk product |
| KR100587551B1 (ko) * | 1997-12-10 | 2006-06-08 | 싸이클로스포린 테라퓨틱스 리미티드 | 오메가-3 지방산 오일을 함유하는 약학 조성물 |
| JP2872986B1 (ja) | 1998-01-21 | 1999-03-24 | 池田食研株式会社 | 高純度高度不飽和脂肪酸の低級アルコールエステル精製方法 |
| US6596302B2 (en) * | 2000-04-13 | 2003-07-22 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| JP2002188096A (ja) * | 2000-10-12 | 2002-07-05 | Kanegafuchi Chem Ind Co Ltd | 新規なグリセリドおよびその製造法並びにその用途 |
| JP2002180082A (ja) | 2000-12-11 | 2002-06-26 | Maruha Corp | 摂取物 |
| ITMI20010129A1 (it) * | 2001-01-25 | 2002-07-25 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco |
| JP4337273B2 (ja) * | 2001-04-20 | 2009-09-30 | 日本水産株式会社 | 基礎代謝増進剤 |
| WO2003005836A2 (en) * | 2001-07-10 | 2003-01-23 | Trustees Of Boston University | Modified-fat nutritional products useful for preventing or treating obesity |
| US20030203004A1 (en) * | 2002-04-24 | 2003-10-30 | Kelm Gary Robert | Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| TW200412942A (en) | 2002-08-06 | 2004-08-01 | Abbott Lab | Appetite control method |
| KR100951758B1 (ko) * | 2002-08-07 | 2010-04-08 | 가오 가부시키가이샤 | 유지 조성물 |
-
2003
- 2003-12-19 SE SE0303513A patent/SE0303513D0/xx unknown
-
2004
- 2004-12-17 CN CNA2004800402112A patent/CN1901897A/zh active Pending
- 2004-12-17 CA CA2549103A patent/CA2549103C/en not_active Expired - Fee Related
- 2004-12-17 US US10/582,978 patent/US9282760B2/en not_active Expired - Fee Related
- 2004-12-17 EP EP10183626A patent/EP2301530A1/en not_active Withdrawn
- 2004-12-17 NZ NZ547831A patent/NZ547831A/en not_active IP Right Cessation
- 2004-12-17 JP JP2006544592A patent/JP2007514733A/ja active Pending
- 2004-12-17 EP EP04806374.7A patent/EP1699449B1/en not_active Expired - Lifetime
- 2004-12-17 AU AU2004305325A patent/AU2004305325B2/en not_active Ceased
- 2004-12-17 WO PCT/IB2004/004178 patent/WO2005060954A1/en not_active Ceased
- 2004-12-17 PL PL04806374T patent/PL1699449T3/pl unknown
- 2004-12-17 CN CN2012102238157A patent/CN102861004A/zh active Pending
- 2004-12-17 ES ES04806374.7T patent/ES2451030T3/es not_active Expired - Lifetime
-
2006
- 2006-07-18 NO NO20063328A patent/NO336507B1/no not_active IP Right Cessation
-
2012
- 2012-05-30 JP JP2012123615A patent/JP2012211147A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1699449A1 (en) | 2006-09-13 |
| EP2301530A1 (en) | 2011-03-30 |
| US9282760B2 (en) | 2016-03-15 |
| NO336507B1 (no) | 2015-09-14 |
| CN1901897A (zh) | 2007-01-24 |
| CA2549103C (en) | 2013-11-26 |
| NO20063328L (no) | 2006-09-19 |
| EP1699449B1 (en) | 2014-01-22 |
| CA2549103A1 (en) | 2005-07-07 |
| ES2451030T3 (es) | 2014-03-26 |
| NZ547831A (en) | 2009-11-27 |
| AU2004305325A1 (en) | 2005-07-07 |
| SE0303513D0 (sv) | 2003-12-19 |
| AU2004305325B2 (en) | 2008-02-07 |
| JP2007514733A (ja) | 2007-06-07 |
| JP2012211147A (ja) | 2012-11-01 |
| WO2005060954A1 (en) | 2005-07-07 |
| CN102861004A (zh) | 2013-01-09 |
| US20070112071A1 (en) | 2007-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1699449T3 (pl) | Zastosowanie kompozycji kwasów tłuszczowych obejmującej co najmniej jeden z EPA i DHA lub jakąkolwiek ich kombinację | |
| IL180602A0 (en) | Composition containing statins and omega-3 fatty acids | |
| HUP0401343A3 (en) | Compositions containing coenzyme q and eicosapentaenoic acid (epa) and their use | |
| GB2409644B (en) | Formulation comprising eicosapentaenoic acid or an ester thereof and a triterpene or an ester thereof | |
| PL377614A1 (pl) | Kompozycje zawierające kwasy tłuszczowe i aminokwasy | |
| IL164984A0 (en) | Use of epa and dha in secondary prevention | |
| IL174925A0 (en) | Glycerophospholipids containing omega -3 and omega-6 fatty acids | |
| EP1801096B8 (en) | Polyglycerol fatty acid ester and composition containing same | |
| GB0301701D0 (en) | Psoriasis and Eicosapentaenoic acid | |
| IL210233A (en) | Formulation of omega-3 fatty acid containing epa and dha and no other active ingredients other than omega-3 fatty acids | |
| AU2003281542A8 (en) | Preparation of microbial oil containing polyunsaturated fatty acids | |
| IL201111A0 (en) | Ester compound and medical use thereof | |
| AU2003259904A8 (en) | Coated polyunsaturated fatty acid-containing particles and coated liquid pharmaceutical-containing particles | |
| PL2218342T3 (pl) | Nowe kompozycje nutraceutyczne i ich zastosowanie | |
| SI2277976T1 (sl) | Sestavki, ki vsebujejo HFC-1234ZE in mazivo | |
| EP1709952B8 (en) | Composition containing polyglycerol/medium-chain fatty acid ester | |
| EP1551384A4 (en) | R-NSAID ESTERS AND ITS USE | |
| AU2003217759A8 (en) | Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression | |
| EP1659848A4 (en) | FATS AND FAT COMPOSITIONS WITH LOW TRANS-FATTY ACID CONTENT AND PROCESS FOR THEIR PREPARATION | |
| AU2003225651A8 (en) | Nematicidal fatty acid and fatty acid ester related compounds | |
| EP1617830A4 (en) | ESTERIFIED FATTY ACID COMPOSITION | |
| ZA200502613B (en) | Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents | |
| TWI348385B (en) | Cosmetic composition containing ester of pentaerythritol and benzoic acid | |
| ZA200600725B (en) | Preparation of metal sals of medium-chain fatty acids | |
| HUP0402490A2 (en) | Antiviral and immunestimulant pharmaceutical composition containing polyunsaturated fatty acid esters |